Namaste: A Party Not to Sell Your Shares??
OHHHH…the NASDAQ is going to have a field day with this rejection.
Namaste Will Never Get a Nasdaq Listing; target $0.25 cents (updated 9:35am)
***UPDATE*** 9:35am Pacific
New information has come to Citron’s attention and its important. New target price $0.25.
The French Presse has spoken and a credit to them. Quoting the head of Quebec Cannabis, Linda Bouchard has spoken. The takeaway is “A situation ‘totally unacceptable’”. It goes on to say, Quebec is to investigate Namaste and the article quotes “in violation of several sections of the Quebec and Canadian laws that formally prohibit the promotion of recreational cannabis products.” The College of Nurses of Quebec even imply that NamasteMD might be illegal (source).
Tilray has now dropped Namaste too – let the hangover begin (source).
Just when you thought you’d seen it all. Two nights ago, in Montreal, Namaste culminated its three-month long pledge challenge with a party featuring Snoop Dogg. This is a $1 billion company that does not grow cannabis, rather they sell vape pens and have a website that did a paltry $46k in revenue last quarter as they lost $9 million.
This is the type of euphoria, hype and promotion that the SEC has been warning investors about.
The last few weeks have been strong for Cannabis stocks that trade in the US and investors have gone feverishly wild in creating bubble like valuations.
While you can’t blame real companies like Aphria and Canntrust on hoping to join the party through a NASDAQ listing, you have to expect some party crashers to show up.
In this case, all we have is a complete stock promotion that purports to to attain what has become an illustrious US listing, but only to dupe investors.
Not So Fast
On Jul 23, 2018, Namaste announced its submission of its application to list on the Nasdaq. The stock is up 125%+ since – congratulations! However, today we will show you how unlikely it is for Namaste to get a Nasdaq listing and why this pledge party will end in a hangover.
Citron 2017 / 2018 Reports
Namaste A Party Not to Sell Your Shares
Our Final Word on $TLRY before $50
Cronos The Dark Side of The Cannabis Space
Wayfair: Citron is listening to the smartest guys in the room
Tilray – Next in line in a Budding Cannabis Industry
$TWTR Just Made the Turn and Is Hitting Stride
Citron Research Explains Why AbbVie is on its way to $60.
Citron Exposes History of FRAUD Behind PolarityTE
Citron expects Netflix to dip back to $340
Fitbit: From Fad to Future
Citron Research Initiates Coverage on Snap Inc. Target Price $17
Citron Changes our Position on ROKU
Inogen Needs to Take a Breath
Citron Research is Bullish on the Most Shorted Stock in the World.
Hailiang Education- China Hustle Déjà vu
Wayfair is Growing Enemies Faster than Customers
Wait til the Senate Hears Twitter’s Hidden Secret
Shopify has a BIG Facebook Problem!
Exact Sciences Corp: We admit to being early. But the science won’t be held back.
Citron Responds to Shopify Conference Call.
Citron chimes in on MiMedx. Countdown to formal investigation. $3 price target
Citron Exposes the Dark Side of shopify The FTC will Take Notice
Update – Questions for Ubiquiti CEO on Investor Day
Citron exposes Ubiquiti Networks
Citron Updates GBTC – What Investors NEED to Know
Motorola Solutions – Total Eclipse of the Truth
FDA FAERS Database Posts Huge Rise in Acthar Deaths and Adverse Events
Today reinforces why $W Wayfair shareholders should be concerned. Multi-channel – Valuation – Supply Chain
NVIDIA to Trade Back to $130
Citron Provides New Proof Why Mallinckrodt is on its way to ZERO
Could Blackberry be the Next NVIDIA?
IF YOU DON’T BELIEVE CITRON BELIEVE THE SCIENCE
Citron Research exposes Exact Sciences and PROVES beyond ANY doubt why this stock will soon be cut in half
Citron Exposes the Dirty Illegal Secrets of FleetCor, and Proof the Company is Already in Cover-Up Mode
FleetCor — Or is it FeeCor or FleeceCor?
Citron Exposes More Undisclosed Relationships at TransDigm
Citron Exposes the Vulnerability of Motorola Solutions — Price Target $45
Express Scripts: Rebate System is a Financial Engineering Kickback Scheme
Could TransDigm be the Valeant of the Aerospace Industry?
Lannett: Citron Exposes the Lawsuits that will Wipe Out the Equity
Citron 2016 & 2015 Report Archives
2016 Reports
2015 Reports
